FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q3 2020

Top Holdings122 positions

Checking export access…
Activity:

IQVIA HLDGS INC

3.5M$555.9M3.8%$117.85+31.33%
8 qtrssince 2018-Q4
Decreased
0

ALPHABET INC

362,629$532.9M3.7%$62.74+16.02%
8 qtrssince 2018-Q4
Increased
84
IMMUIMMUDelisted

IMMUNOMEDICS INC

5.9M$498.3M3.4%——
1 qtr
New
87

THERMO FISHER SCIENTIFIC INC

1.1M$483.7M3.3%$309.38+40.40%
4 qtrssince 2019-Q4
Increased
59

FIDELITY NATL INFORMATION SV

3.2M$465.6M3.2%$102.06+30.17%
8 qtrssince 2018-Q4
Decreased
0

CHARTER COMMUNICATIONS INC

733,191$457.8M3.2%$304.08+106.03%
8 qtrssince 2018-Q4
Decreased
0

T-MOBILE US INC

3.6M$415.9M2.9%$99.51+9.27%
2 qtrssince 2020-Q2
Increased
56

CENTENE CORP DEL

7.1M$411.2M2.8%$59.40-1.81%
3 qtrssince 2020-Q1
Increased
54

META PLATFORMS INC

1.5M$403.9M2.8%$173.75+49.62%
8 qtrssince 2018-Q4
Increased
61

ABBVIE INC

4.3M$372.3M2.6%$61.91+11.52%
5 qtrssince 2019-Q3
Increased
55

AON PLC

1.8M$362.3M2.5%$184.49+7.18%
2 qtrssince 2020-Q2
Increased
54

VISA INC

1.7M$343.3M2.4%$139.11+37.60%
8 qtrssince 2018-Q4
Decreased
0

ELEVANCE HEALTH INC FORMERLY

1.3M$342.5M2.4%$246.70-1.89%
8 qtrssince 2018-Q4
Increased
54

WABTEC

5.4M$336.6M2.3%$62.64-4.49%
8 qtrssince 2018-Q4
Increased
65

MICROSOFT CORP

1.5M$324.1M2.2%$116.92+71.08%
8 qtrssince 2018-Q4
Increased
53
EMBEMB
PUT

ISHARES TR

288,900$320.4M2.2%———
New
—

BOSTON SCIENTIFIC CORP

8.3M$316.2M2.2%$38.210.00%
1 qtr
New
80

NEW YORK TIMES CO MTN BE

7.1M$304.1M2.1%$39.90-0.19%
2 qtrssince 2020-Q2
Increased
79
3.8M$299.4M2.1%——
8 qtrssince 2018-Q4
Decreased
0

ACCELERON PHARMA INC

2.6M$292.6M2.0%——
8 qtrssince 2018-Q4
Increased
64
$14.5B
AUM
122
Positions
Q3 2020
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+18%Q2'19$14.3B-15%Q3'19$12.2B+6%Q4'19$13B-16%Q1'20$10.9B+14%Q2'20$12.4B+13%Q3'20$14.1B
Activity profile
$ moved · Q3'20
New34%Increased33%Decreased9%Exited24%
Composition
Equity vs derivatives
Equity98%Puts2%Calls0%
Holding period
Avg 3.5 quarters
<1Q24%1-4Q32%1-2Y44%2Y+0%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $14.5B across 122 positions as of Q3 2020. Top holdings: IQV (3.8%), GOOG (3.7%), IMMU (3.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Q3 2020 Summary

Active quarter - 32 new positions, 29 exits, 59 increased. Top move: IMMU (NEW, conviction 87). Portfolio: $14.5B across 122 positions.

Top holdings by portfolio weight

Total AUM$14B
IQV3.85%
GOOG3.69%
IMMU3.45%
TMO3.35%
FIS3.22%
CHTR3.17%
TMUS2.88%
CNC2.84%
META2.79%
ABBV2.57%
Other2.51%

Portfolio allocation by GICS sector

Sectors10
Healthcare35.36%
Unknown20.58%
Communication Services15.72%
Technology8.79%
Financial Services7.95%
Industrials5.27%
Consumer Cyclical2.32%
Basic Materials2.10%
Real Estate1.40%
Utilities0.51%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L45
Conviction44
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+9M shares+$755.7M
7Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q4 2024 → Q2 2026+7.8M shares+$277M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 → Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used